Clinical trial
Combination Chemotherapy Plus Radiation Therapy Followed By Surgery in Treating…
NCT00006472 · Medstar Health Research Institute, Other · Terminated
Key facts
| NCT number | NCT00006472 |
|---|---|
| Title | Combination Chemotherapy Plus Radiation Therapy Followed By Surgery in Treating Patients With Stage I, Stage II, or Stage III Esophageal Cancer |
| Official title | Esophageal Cancer: A Phase II Study of Paclitaxel, Carboplatin and 5-Fluorouracil With Simultaneous Radiotherapy Followed by Surgical Resection |
| Lead sponsor | Medstar Health Research Institute, Other |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Esophageal Cancer |
| Intervention type | Drug, Procedure, Radiation |
| Interventions | carboplatin, fluorouracil, paclitaxel, conventional surgery, radiation therapy |
| Enrollment | 4 |
| Start date | Jan 1, 2000 |
| Primary completion | Nov 15, 2001 |
| Completion | Sep 10, 2002 |
| First posted | Feb 26, 2004 |
| Last update posted | Aug 18, 2020 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: